Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Elaine Morrato to United States

This is a "connection" page, showing publications Elaine Morrato has written about United States.

 
Connection Strength
 
 
 
0.984
 
  1. Toyserkani GA, Ewusie SB, Turk P, Quick J, Morrato EH. Evolution of Cross-Sectional Survey Protocol Quality Over Time: A Case Series of Index U.S. REMS Knowledge Survey Protocols (2007-2020). Drug Saf. 2023 11; 46(11):1073-1087.
    View in: PubMed
    Score: 0.065
  2. Schuster ALR, Perraillon MC, Paul JJ, Leiferman JA, Battaglia C, Morrato EH. The Effect of the Affordable Care Act on Women's Postpartum Insurance and Depression in 5 States That Did Not Expand Medicaid, 2012-2015. Med Care. 2022 01 01; 60(1):22-28.
    View in: PubMed
    Score: 0.057
  3. Huynh L, Toyserkani GA, Morrato EH. Pragmatic applications of implementation science frameworks to regulatory science: an assessment of FDA Risk Evaluation and Mitigation Strategies (REMS) (2014-2018). BMC Health Serv Res. 2021 Aug 06; 21(1):779.
    View in: PubMed
    Score: 0.056
  4. Toyserkani GA, Huynh L, Morrato EH. Adaptation for Regulatory Application: A Content Analysis of FDA Risk Evaluation and Mitigation Strategies Assessment Plans (2014-2018) Using RE-AIM. Front Public Health. 2020; 8:43.
    View in: PubMed
    Score: 0.050
  5. McManus BM, Richardson Z, Schenkman M, Murphy NJ, Everhart RM, Hambidge S, Morrato E. Child characteristics and early intervention referral and receipt of services: a retrospective cohort study. BMC Pediatr. 2020 02 22; 20(1):84.
    View in: PubMed
    Score: 0.050
  6. Morrato EH, Campagna EJ, Brewer SE, Dickinson LM, Thomas DS, Miller BF, Dearing J, Druss BG, Lindrooth RC. Metabolic Testing for Adults in a State Medicaid Program Receiving Antipsychotics: Remaining Barriers to Achieving Population Health Prevention Goals. JAMA Psychiatry. 2016 Jul 01; 73(7):721-30.
    View in: PubMed
    Score: 0.039
  7. Morrato EH, Brewer SE, Campagna EJ, Dickinson LM, Thomas DS, Druss BG, Miller BF, Newcomer JW, Lindrooth RC. Glucose Testing for Adults Receiving Medicaid and Antipsychotics: A Population-Based Prescriber Survey on Behaviors, Attitudes, and Barriers. Psychiatr Serv. 2016 07 01; 67(7):798-802.
    View in: PubMed
    Score: 0.039
  8. Nicol GE, Campagna EJ, Garfield LD, Newcomer JW, Parks JJ, Morrato EH. The Role of Clinical Setting and Management Approach in Metabolic Testing Among Youths and Adults Treated With Antipsychotics. Psychiatr Serv. 2016 Jan; 67(1):128-32.
    View in: PubMed
    Score: 0.037
  9. Morrato EH, Rabin B, Proctor J, Cicutto LC, Battaglia CT, Lambert-Kerzner A, Leeman-Castillo B, Prahl-Wretling M, Nuechterlein B, Glasgow RE, Kempe A. Bringing it home: expanding the local reach of dissemination and implementation training via a university-based workshop. Implement Sci. 2015 Jul 04; 10:94.
    View in: PubMed
    Score: 0.037
  10. Morrato EH, Parks J, Campagna EJ, Muser E, Thomas DS, Fang H, Doshi D. Comparative effectiveness of injectable paliperidone palmitate versus oral atypical antipsychotics: early postmarketing evidence. J Comp Eff Res. 2015 Mar; 4(2):89-99.
    View in: PubMed
    Score: 0.035
  11. Root ED, Thomas DS, Campagna EJ, Morrato EH. Adjusting for geographic variation in observational comparative effectiveness studies: a case study of antipsychotics using state Medicaid data. BMC Health Serv Res. 2014 Aug 27; 14:355.
    View in: PubMed
    Score: 0.034
  12. Campagna EJ, Muser E, Parks J, Morrato EH. Methodological considerations in estimating adherence and persistence for a long-acting injectable medication. J Manag Care Spec Pharm. 2014 Jul; 20(7):756-66.
    View in: PubMed
    Score: 0.034
  13. Morrato EH, Concannon TW, Meissner P, Shah ND, Turner BJ. Dissemination and implementation of comparative effectiveness evidence: key informant interviews with Clinical and Translational Science Award institutions. J Comp Eff Res. 2013 Mar; 2(2):185-94.
    View in: PubMed
    Score: 0.031
  14. Morrato EH, Ling SB. The Drug Safety and Risk Management Advisory Committee: a case study of meeting frequency, content, and outcomes before and after FDAAA. Med Care. 2012 Nov; 50(11):970-86.
    View in: PubMed
    Score: 0.030
  15. Morrato EH, Allison DB. FDA approval of obesity drugs: a difference in risk-benefit perceptions. JAMA. 2012 Sep 19; 308(11):1097-8.
    View in: PubMed
    Score: 0.030
  16. Morrato EH, Druss BG, Hartung DM, Valuck RJ, Thomas D, Allen R, Campagna E, Newcomer JW. Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users. Pharmacoepidemiol Drug Saf. 2011 Jan; 20(1):66-75.
    View in: PubMed
    Score: 0.027
  17. Morrato EH, Nicol GE, Maahs D, Druss BG, Hartung DM, Valuck RJ, Campagna E, Newcomer JW. Metabolic screening in children receiving antipsychotic drug treatment. Arch Pediatr Adolesc Med. 2010 Apr; 164(4):344-51.
    View in: PubMed
    Score: 0.025
  18. Morrato EH, Druss B, Hartung DM, Valuck RJ, Allen R, Campagna E, Newcomer JW. Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs. Arch Gen Psychiatry. 2010 Jan; 67(1):17-24.
    View in: PubMed
    Score: 0.025
  19. Morrato EH, Newcomer JW, Kamat S, Baser O, Harnett J, Cuffel B. Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes. Diabetes Care. 2009 Jun; 32(6):1037-42.
    View in: PubMed
    Score: 0.024
  20. Morrato EH, Cuffel B, Newcomer JW, Lombardo I, Kamat S, Barron J. Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients. J Clin Psychopharmacol. 2009 Feb; 29(1):26-32.
    View in: PubMed
    Score: 0.023
  21. Morrato EH, Newcomer JW, Allen RR, Valuck RJ. Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data. J Clin Psychiatry. 2008 Feb; 69(2):316-22.
    View in: PubMed
    Score: 0.022
  22. Morrato EH, Libby AM, Orton HD, Degruy FV, Brent DA, Allen R, Valuck RJ. Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry. 2008 Jan; 165(1):42-50.
    View in: PubMed
    Score: 0.022
  23. Morrato EH, Elias M, Gericke CA. Using population-based routine data for evidence-based health policy decisions: lessons from three examples of setting and evaluating national health policy in Australia, the UK and the USA. J Public Health (Oxf). 2007 Dec; 29(4):463-71.
    View in: PubMed
    Score: 0.021
  24. Morrato EH, Hill JO, Wyatt HR, Ghushchyan V, Sullivan PW. Physical activity in U.S. adults with diabetes and at risk for developing diabetes, 2003. Diabetes Care. 2007 Feb; 30(2):203-9.
    View in: PubMed
    Score: 0.020
  25. Morrato EH, Staffa JA. Effectiveness of risk management plans: a case study of pemoline using pharmacy claims data. Pharmacoepidemiol Drug Saf. 2007 Jan; 16(1):104-12.
    View in: PubMed
    Score: 0.020
  26. Lind KE, Hildreth K, Lindrooth R, Morrato E, Crane LA, Perraillon MC. The effect of direct cognitive assessment in the Medicare annual wellness visit on dementia diagnosis rates. Health Serv Res. 2021 04; 56(2):193-203.
    View in: PubMed
    Score: 0.013
  27. Russell AM, Morrato EH, Lovett RM, Smith MY. Quality of Reporting on the Evaluation of Risk Minimization Programs: A Systematic Review. Drug Saf. 2020 05; 43(5):427-446.
    View in: PubMed
    Score: 0.013
  28. Lind KE, Hildreth K, Lindrooth R, Crane LA, Morrato E, Perraillon MC. Ethnoracial Disparities in Medicare Annual Wellness Visit Utilization: Evidence From a Nationally Representative Database. Med Care. 2018 09; 56(9):761-766.
    View in: PubMed
    Score: 0.011
  29. Lind KE, Hildreth K, Lindrooth R, Morrato E, Crane LA, Perraillon MC. Effect of Medicare Part D on Ethnoracial Disparities in Antidementia Medication Use. J Am Geriatr Soc. 2018 09; 66(9):1760-1767.
    View in: PubMed
    Score: 0.011
  30. S?mme S, Bronsert M, Morrato E, Ziegler M. Frequency and variety of inpatient pediatric surgical procedures in the United States. Pediatrics. 2013 Dec; 132(6):e1466-72.
    View in: PubMed
    Score: 0.008
  31. Erickson MA, Morrato EH, Campagna EJ, Elise B, Miller NH, Kempe A. Variability in spinal surgery outcomes among children's hospitals in the United States. J Pediatr Orthop. 2013 Jan; 33(1):80-90.
    View in: PubMed
    Score: 0.008
  32. S?mme S, Bronsert M, Kempe A, Morrato EH, Ziegler M. Alignment of training curriculum and surgical practice: implications for competency, manpower, and practice modeling. Eur J Pediatr Surg. 2012 Feb; 22(1):74-9.
    View in: PubMed
    Score: 0.007
  33. Druss BG, Zhao L, Von Esenwein S, Morrato EH, Marcus SC. Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care. 2011 Jun; 49(6):599-604.
    View in: PubMed
    Score: 0.007
  34. Fox D, Morrato E, Campagna EJ, Rees DI, Dickinson LM, Partrick DA, Kempe A. Outcomes of laparoscopic versus open fundoplication in children's hospitals: 2005-2008. Pediatrics. 2011 May; 127(5):872-80.
    View in: PubMed
    Score: 0.007
  35. Nicol GE, Morrato EH, Johnson MC, Campagna E, Yingling MD, Pham V, Newcomer JW. Best practices: implementation of a glucose screening program based on diffusion of innovation theory methods. Psychiatr Serv. 2011 Jan; 62(1):12-4.
    View in: PubMed
    Score: 0.007
  36. Banta JE, Morrato EH, Lee SW, Haviland MG. Retrospective analysis of diabetes care in California Medicaid patients with mental illness. J Gen Intern Med. 2009 Jul; 24(7):802-8.
    View in: PubMed
    Score: 0.006
  37. Dillon P, Hammermeister K, Morrato E, Kempe A, Oldham K, Moss L, Marchildon M, Ziegler M, Steeger J, Rowell K, Shiloach M, Henderson W. Developing a NSQIP module to measure outcomes in children's surgical care: opportunity and challenge. Semin Pediatr Surg. 2008 May; 17(2):131-40.
    View in: PubMed
    Score: 0.006
  38. Valuck RJ, Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R. How expensive is antipsychotic polypharmacy? Experience from five US state Medicaid programs. Curr Med Res Opin. 2007 Oct; 23(10):2567-76.
    View in: PubMed
    Score: 0.005
  39. Valuck RJ, Libby AM, Orton HD, Morrato EH, Allen R, Baldessarini RJ. Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry. 2007 Aug; 164(8):1198-205.
    View in: PubMed
    Score: 0.005
  40. Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry. 2007 Jun; 164(6):884-91.
    View in: PubMed
    Score: 0.005
  41. McCollum M, Ellis SL, Morrato EH, Sullivan PW. Prevalence of multiple cardiac risk factors in US adults with diabetes. Curr Med Res Opin. 2006 Jun; 22(6):1031-4.
    View in: PubMed
    Score: 0.005
  42. Sullivan PW, Morrato EH, Ghushchyan V, Wyatt HR, Hill JO. Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002. Diabetes Care. 2005 Jul; 28(7):1599-603.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)